Armata Pharmaceuticals (ARMP) Free Cash Flow (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.10% |
| Dec 31, 2025 | -48.15% |
| Sep 30, 2025 | 38.32% |
| Jun 30, 2025 | 4.15% |
| Mar 31, 2025 | 2.18% |
| Dec 31, 2024 | 14.70% |
| Sep 30, 2024 | 20.27% |
| Jun 30, 2024 | -6.54% |
| Mar 31, 2024 | -3.12% |
| Dec 31, 2023 | 20.40% |
| Sep 30, 2023 | -7.47% |
| Jun 30, 2023 | 37.27% |
| Mar 31, 2023 | -95.21% |
| Dec 31, 2022 | 13.74% |
| Sep 30, 2022 | -25.24% |
| Jun 30, 2022 | -147.51% |
| Mar 31, 2022 | 57.50% |
| Dec 31, 2021 | -59.14% |
| Sep 30, 2021 | -17.15% |
| Jun 30, 2021 | 18.00% |
| Mar 31, 2021 | 13.42% |
| Dec 31, 2020 | -68.34% |
| Sep 30, 2020 | 4.07% |
| Jun 30, 2020 | 4.77% |
| Mar 31, 2020 | -57.67% |
| Dec 31, 2019 | 38.92% |
| Sep 30, 2019 | 24.37% |
| Jun 30, 2019 | -128.87% |
| Mar 31, 2019 | 27.47% |
| Dec 31, 2018 | -64.87% |
| Sep 30, 2018 | -15.94% |
| Jun 30, 2018 | 46.95% |
| Mar 31, 2018 | -48.14% |
| Dec 31, 2017 | -281.31% |
| Sep 30, 2017 | 78.66% |
| Jun 30, 2017 | 11.23% |
| Mar 31, 2017 | -118.66% |
| Dec 31, 2016 | 52.18% |
| Sep 30, 2016 | -4.74% |
| Jun 30, 2016 | 5.63% |